PNC Financial Services Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-168
| Closed | -$1K | – | 4305 |
|
|
2018
Q3 | $1K | Buy |
+168
| New | +$1K | ﹤0.01% | 4091 |
|
|
2016
Q3 | – | Sell |
-501
| Closed | -$3K | – | 4471 |
|
|
2016
Q2 | $3K | Sell |
501
-20
| -4% | -$120 | ﹤0.01% | 4091 |
|
|
2016
Q1 | $2K | Buy |
521
+18
| +4% | +$69 | ﹤0.01% | 4274 |
|
|
2015
Q4 | $3K | Hold |
503
| – | – | ﹤0.01% | 4085 |
|
|
2015
Q3 | $2K | Sell |
503
-168
| -25% | -$668 | ﹤0.01% | 4361 |
|
|
2015
Q2 | $7K | Buy |
671
+272
| +68% | +$2.84K | ﹤0.01% | 3968 |
|
|
2015
Q1 | $5K | Buy |
399
+135
| +51% | +$1.69K | ﹤0.01% | 4043 |
|
|
2014
Q4 | $4K | Sell |
264
-1,900
| -88% | -$28.8K | ﹤0.01% | 3621 |
|
|
2014
Q3 | $30K | Buy |
2,164
+1,900
| +720% | +$26.3K | ﹤0.01% | 2904 |
|
|
2014
Q2 | $4K | Sell |
264
-625
| -70% | -$9.47K | ﹤0.01% | 3391 |
|
|
2014
Q1 | $15K | Buy |
+889
| New | +$15K | ﹤0.01% | 2952 |
|